Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro

BACKGROUND: Fibrinogen concentrates and cryoprecipitate are currently used for fibrinogen supplementation in bleeding patients with dysfibrinogenemia. Both products provide an abundant source of fibrinogen but take greater than 10 min to prepare for administration. Fibrinogen concentrates lack coagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Kimberly A., Shea, Susan M., Spinella, Philip C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252673/
https://www.ncbi.nlm.nih.gov/pubmed/33755208
http://dx.doi.org/10.1111/trf.16376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252673/
https://www.ncbi.nlm.nih.gov/pubmed/33755208
http://dx.doi.org/10.1111/trf.16376

Ejemplares similares